advertisement

---

Bunce C 11

Showing records 1 to 11 | Display all abstracts from Bunce C

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Quartilho A
Eye 2016; 30: 602-607

---

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Vickerstaff V; Ambler G
Trials 2015; 16: 517

---

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Simkiss P
Eye 2016; 30: 602-607

---

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Bunce C
Trials 2015; 16: 517

---

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Zekite A
Eye 2016; 30: 602-607

---

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Xing W
Trials 2015; 16: 517

---

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Xing W
Eye 2016; 30: 602-607

---

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial
Gazzard G
Trials 2015; 16: 517

---

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Wormald R
Eye 2016; 30: 602-607

---

65948 Statistical analysis plan for the Laser-1st versus Drops-1st for Glaucoma and Ocular Hypertension Trial (LiGHT): a multi-centre randomised controlled trial

Trials 2015; 16: 517

---

66513 Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013
Bunce C
Eye 2016; 30: 602-607

---